These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 16153922)

  • 21. Automated quantitative analysis of E-cadherin expression in lymph node metastases is predictive of survival in invasive ductal breast cancer.
    Harigopal M; Berger AJ; Camp RL; Rimm DL; Kluger HM
    Clin Cancer Res; 2005 Jun; 11(11):4083-9. PubMed ID: 15930343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma.
    Pfannschmidt J; Bade S; Hoheisel J; Muley T; Dienemann H; Herpel E
    Thorac Cardiovasc Surg; 2009 Oct; 57(7):403-8. PubMed ID: 19795327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer.
    Sakao Y; Miyamoto H; Yamazaki A; Oh T; Fukai R; Shiomi K; Saito Y
    Ann Thorac Surg; 2006 Jan; 81(1):292-7. PubMed ID: 16368383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new formula for predicting liver metastasis in patients with colorectal cancer: immunohistochemical analysis of a large series of 439 surgically resected cases.
    Ochiai H; Nakanishi Y; Fukasawa Y; Sato Y; Yoshimura K; Moriya Y; Kanai Y; Watanabe M; Hasegawa H; Kitagawa Y; Kitajima M; Hirohashi S
    Oncology; 2008; 75(1-2):32-41. PubMed ID: 18728370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of E-cadherin in cervical lymph nodes from primary oral squamous cell carcinoma patients.
    Zhong LP; Li J; Zhang CP; Zhu HG; Sun J; Zhang ZY
    Arch Oral Biol; 2007 Aug; 52(8):740-7. PubMed ID: 17331461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The value of E-cadherin/beta-catenin expression in imprints of NCSLC: relationship with clinicopathological factors.
    Pagaki E; Patsouris E; Gonidi M; Athanassiadou AM; Maurikakis M; Athanassiades P; Chelidonis G; Athanassiadou P
    Diagn Cytopathol; 2010 Jun; 38(6):419-24. PubMed ID: 20474081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemical evaluation of E-cadherin and epidermal growth factor receptor in non-small cell lung cancer.
    Sorscher SM; Russack V; Graziano S; Cagle M; Feramisco JR; Green MR
    Mod Pathol; 1995 May; 8(4):450-5. PubMed ID: 7567948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of E-cadherin, and CD44s and CD44v6 and its association with prognosis in head and neck cancer.
    Kawano T; Nakamura Y; Yanoma S; Kubota A; Furukawa M; Miyagi Y; Tsukuda M
    Auris Nasus Larynx; 2004 Mar; 31(1):35-41. PubMed ID: 15041052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of E-cadherin (E-CD) as related to other prognostic factors and survival in breast cancer.
    Lipponen P; Saarelainen E; Ji H; Aaltomaa S; Syrjänen K
    J Pathol; 1994 Oct; 174(2):101-9. PubMed ID: 7965405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The methylation status and protein expression of CDH1, p16(INK4A), and fragile histidine triad in nonsmall cell lung carcinoma: epigenetic silencing, clinical features, and prognostic significance.
    Nakata S; Sugio K; Uramoto H; Oyama T; Hanagiri T; Morita M; Yasumoto K
    Cancer; 2006 May; 106(10):2190-9. PubMed ID: 16598757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation between survivin expression and prognosis in non-small cell lung cancer.
    Atikcan S; Unsal E; Demirag F; Köksal D; Yilmaz A
    Respir Med; 2006 Dec; 100(12):2220-6. PubMed ID: 16650973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of nuclear factor-kappaB and its clinical significance in nonsmall-cell lung cancer.
    Zhang Z; Ma J; Li N; Sun N; Wang C
    Ann Thorac Surg; 2006 Jul; 82(1):243-8. PubMed ID: 16798222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
    De Petris L; Orre LM; Kanter L; Pernemalm M; Koyi H; Lewensohn R; Lehtiö J
    Lung Cancer; 2009 Mar; 63(3):410-7. PubMed ID: 18620780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of E-cadherin-catenin complex in epithelial ovarian cancer.
    Voutilainen KA; Anttila MA; Sillanpää SM; Ropponen KM; Saarikoski SV; Juhola MT; Kosma VM
    J Clin Pathol; 2006 May; 59(5):460-7. PubMed ID: 16461565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Expressions of Nm23, E-cadherin, and beta-catenin in non-small cell lung cancer and their correlations with metastasis and prognosis].
    Tang XJ; Zhou QH; Zhang SF; Liu LX
    Ai Zheng; 2005 May; 24(5):616-21. PubMed ID: 15890109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of CyclinD1 and E-Cadherin in patients with esophageal squamous cell carcinoma: multiinstitutional retrospective analysis. Research Committee on Malignancy of Esophageal Cancer, Japanese Society for Esophageal Diseases.
    J Am Coll Surg; 2001 Jun; 192(6):708-18. PubMed ID: 11400964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prognostic value of E-cadherin, alpha-, beta- and gamma-catenin in bladder cancer patients who underwent radical cystectomy.
    Kashibuchi K; Tomita K; Schalken JA; Kume H; Takeuchi T; Kitamura T
    Int J Urol; 2007 Sep; 14(9):789-94. PubMed ID: 17760743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical significance of prostate stem cell antigen expression in non-small cell lung cancer.
    Kawaguchi T; Sho M; Tojo T; Yamato I; Nomi T; Hotta K; Hamada K; Suzaki Y; Sugiura S; Kushibe K; Nakajima Y; Taniguchi S
    Jpn J Clin Oncol; 2010 Apr; 40(4):319-26. PubMed ID: 20085909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. E-cadherin expression in invasive non-lobular carcinoma of the breast and its prognostic significance.
    Rakha EA; Abd El Rehim D; Pinder SE; Lewis SA; Ellis IO
    Histopathology; 2005 Jun; 46(6):685-93. PubMed ID: 15910600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Laminin and cathepsin B as prognostic factors in stage I non-small cell lung cancer: are they useful?
    Mori M; Kohli A; Baker SP; Savas L; Fraire AE
    Mod Pathol; 1997 Jun; 10(6):572-7. PubMed ID: 9195574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.